Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Kush Andrew
2. Date of Event Requiring Statement (Month/Day/Year)
04/11/2017
3. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [HCSG]
(Last)
(First)
(Middle)
3220 TILLMAN DRIVE, SUITE 300
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive Vice President
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

BENSALEM, PA 19020
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 660
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock (1)   (2)   (2) Common Stock 1,820 $ 0 D  
Restricted Stock   (3)   (3) Common Stock 140 $ 0 D  
Restricted Stock   (4)   (4) Common Stock 375 $ 0 D  
Restricted Stock   (5)   (5) Common Stock 800 $ 0 D  
Restricted Stock Units   (6)   (6) Common Stock 8,500 $ 0 D  
Stock Option (right to buy)   (7) 01/06/2021 Common Stock 2,000 $ 16.11 D  
Stock Option (right to buy)   (7) 01/05/2022 Common Stock 5,000 $ 17.5 D  
Stock Option (right to buy)   (8) 01/04/2023 Common Stock 5,000 $ 23.5 D  
Stock Option (right to buy)   (9) 01/03/2024 Common Stock 5,000 $ 28.02 D  
Stock Option (right to buy)   (10) 01/05/2025 Common Stock 5,000 $ 30.3 D  
Stock Option (right to buy)   (11) 01/04/2026 Common Stock 6,000 $ 34.14 D  
Stock Option (right to buy)   (12) 01/04/2027 Common Stock 6,000 $ 39.38 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Kush Andrew
3220 TILLMAN DRIVE
SUITE 300
BENSALEM, PA 19020
      Executive Vice President  

Signatures

John C. Shea, by Power of Attorney 04/21/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.
(2) Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer.
(3) These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date, and as such, 210 of these awards have already vested.
(4) These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date, and as such, 250 of these awards have already vested.
(5) These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date, and as such, 200 of these awards have already vested.
(6) These Restricted Stock Units shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.
(7) These options have fully vested.
(8) These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2013 grant date.
(9) These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date.
(10) These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date.
(11) These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date.
(12) These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.